Skip to content

News

The Overview: December 2020

The Overview: December 2020

We’re probably all ready to say goodbye to 2020, if we have to be honest with ourselves. And yet, we can’t look back and say that the year was entirely bad. With your support, OCRA actually accomplished quite a lot and we have much for which to feel hopeful. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS WAYS TO GIVE … Continued

OCRA Research Investigates Role of Extracellular Vesicles in Cancer Research

OCRA Research Investigates Role of Extracellular Vesicles in Cancer Research

OCRA-funded researchers Dr. Sunila Pradeep and Dr. Pradeep Chaluvally-Raghavan, both at the Medical College of Wisconsin, along with colleagues, summarized recent literature on the function of extracellular vesicles “in regulating the critical processes associated with cancer progression.” Their review, published in the journal Cancers, also provides insights on how these vesicles are used as biomarkers … Continued

Applying Computational Biology to Ovarian Cancer | Meet a Scientist

Applying Computational Biology to Ovarian Cancer | Meet a Scientist

Could the next ovarian cancer breakthrough be traced back to a Commodore 64 home computer? After all, in some small measure, OCRA grantee Dr. Sohrab Shah is where he is today thanks to that now-antiquated instrument. He was 11 or 12 years old, tinkering around with programming at home, when he became captivated with what … Continued

OCRA-Funded Scientists Further Study Gene Mutation Connected to Ovarian Cancer

OCRA-Funded Scientists Further Study Gene Mutation Connected to Ovarian Cancer

An international collaborative of scientists, including Dr. Ronald Chandler at Michigan State University, studied ARID1A mutations, which are specific gene mutations observed in deep ovarian and deep infiltrating endometriosis. The authors of the study noted that seeing a high frequency of these mutations in deep ovarian endometriosis supports evidence linking this to endometriosis-associated ovarian cancer. … Continued

The Overview: November 2020

The Overview: November 2020

We’re full on into fall, and giving thanks for all that we’ve accomplished together, in a year that’s been more than a little challenging. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS TO GIVE

What’s New in Ovarian Cancer Research and Treatment

What’s New in Ovarian Cancer Research and Treatment

A bright spot in 2020 for the ovarian cancer community has been the ongoing developments in research and treatments. Advances continue to be made, as researchers study the effectiveness of PARP inhibitors as maintenance therapy for ovarian cancer, the most effective way to implement immunotherapy agents, the key factors that can affect the success of … Continued

Watch Expert Presentations from OCRA’s 2020 Virtual National Conference

Watch Expert Presentations from OCRA’s 2020 Virtual National Conference

Want to learn what’s new in ovarian cancer research and care for 2020? Start here. This fall, we hosted our virtual Uniting for Hope Ovarian Cancer National Conference, where experts in the field presented on a wide range of topics– demystifying genetic testing and precision medicine, providing resources for financial support, explaining clinical trials, and … Continued

OCRA Hosts Listening Session With FDA About COVID-19

OCRA Hosts Listening Session With FDA About COVID-19

In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA listening session in the video below.

The Overview: October 2020

The Overview: October 2020

It’s been an incredibly busy end of summer/beginning of fall here at OCRA with a double header of Ovarian Cancer Awareness Month and our Uniting for Hope Ovarian Cancer National Conference. We’ve learned so much and strengthened our community. Here are just some of the ways: RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS OCRA HEROES EVENTS WAYS TO … Continued

OCRA-Funded Research Shines Light on Genetic Factors that Contribute to Diagnosis

OCRA-Funded Research Shines Light on Genetic Factors that Contribute to Diagnosis

In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or possibly delay, the onset of the disease. “We found there were various genes that would help the process along, but interestingly, there were other genes … Continued

Heated Intraperitoneal Chemotherapy Found to Improve Outcomes in Patients with Stage III Epithelial Ovarian Cancer

Heated Intraperitoneal Chemotherapy Found to Improve Outcomes in Patients with Stage III Epithelial Ovarian Cancer

A new study found that patients who received heated intraperitoneal chemotherapy (HIPEC) after surgery lived almost 16 months longer than patients who were treated by surgery alone. Conducted with data from 584 patients with stage III epithelial ovarian cancer from multiple treatment centers, this study is the largest to date looking at the effects of … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.